<DOC>
	<DOCNO>NCT01556126</DOCNO>
	<brief_summary>The aim study evaluate safety efficacy performance CRE8 Drug Eluting Stent , patient comparable everyday 's clinical practice population , specific focus diabetic , part pre-specified study subgroup .</brief_summary>
	<brief_title>Clinical Performance CRE8 Drug Eluting Stent All Comer Population</brief_title>
	<detailed_description />
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Angina Pectoris</mesh_term>
	<mesh_term>Angina , Unstable</mesh_term>
	<mesh_term>Angina , Stable</mesh_term>
	<criteria>Age &gt; 18 year ; Patients symptoms stable angina documented silent ischemia ; Patient coronary artery disease range 0 22 accord Syntax score ; Patients acute coronary syndrome , include unstable angina , NSTEMI STEMI ; Patient eligible percutaneous coronary intervention ( PCI ) acceptable candidate surgical revascularization ( CABG ) ; Left ventricular ejection fraction &gt; 30 % ; Target denovo lesion diameter stenosis &gt; 50 % ( include total occlusion ) ; Target lesion locate target vessel diameter range 2.5 4.0 mm ; Patient inform nature study agree provision provide write informed consent approve Ethical Committee respective clinical site . Female childbearing potential lactating ; Known allergy antiplatelets , anticoagulant , contrast medium , sirolimus cobalt chromium ; Acute chronic renal dysfunction ( define creatinine great 2.5 mg/dl dialysis ) ; Thrombocytopenia ( platelet count le 100,000/mmÂ³ ) hypercoagulable disorder ; Known significant gastrointestinal urinary bleeding within past 6 month ; Patient refuse blood transfusion ; Patient currently immunosuppressant therapy ; Patient plan surgery within 6 month index procedure unless dual antiplatelet therapy maintain throughout perisurgical period ; Comorbidities could interfere completion study procedure , life expectancy le 1 year ; Participating another investigational drug device trial complete primary endpoint would interfere endpoint study ; Patient underwent target vessel revascularization DES within 3 month prior index procedure ; Target lesion locate supplied arterial venous bypass graft .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>Coronary artery disease</keyword>
	<keyword>Drug Eluting Stent</keyword>
	<keyword>All comer patient</keyword>
</DOC>